Top 10 Cancer Research Stories of 2020
Top 10 Cancer Research Stories of 2020
"Cancer didn’t get put on pause this year and neither did we."
This year, some researchers turned their attention to addressing COVID’s direct impact on cancer patients. Others worked to develop new drugs or make immunotherapy treatments work better. Physicians and generous patients contributed to the forward progress of new medicines through clinical trials. Bench scientists deepened our understanding of cancer’s pernicious biology. And still others worked to understand cancer at the population level and to address racial and ethnic disparities.
Throughout the pandemic, researchers have continued to push the boundaries of cancer prevention, diagnosis and treatment.
Among hundreds of discoveries big and small, these were the cancer centre’s top stories of 2020:
1. New Map of the Immune Landscape in Pancreatic Cancer Could Guide Future Personalized Immunotherapy Treatments: The analysis highlights the diversity of immune response in pancreatic cancer, and points toward the need for treatments tailored to individual patients.
2. New Connections Reveal How Cancer Evades the Immune System: The study shows tumor cells eat up a key amino acid, depriving immune cells of it, which prevents them from fighting off cancer.
3. ‘The Immense Burden of Cancer is Not Shouldered Equally’: We contributed to a first-ever report describing how overall gains against cancer are not benefiting some racial and ethnic groups – and how COVID-19 may be making it worse.
4. App Calculates Risk of Delaying Cancer Care During Pandemic: The University of Michigan’s OncCOVID app draws on global cancer and coronavirus data to create an individualized mortality risk assessment for receiving immediate versus delayed cancer treatment.
5. How Hereditary Genetic Testing Results Impact Breast Cancer Treatment: A study finds breast cancer patients with an inherited genetic mutation don’t always get treatment that follows guidelines.
6. Anti-Leukemia Compound Induces Complete Remission in Mouse Models: A Phase I clinical trial using a structurally related analog of the compound is currently enrolling patients.
7. Study Suggests New Potential Approach Against Fatal Childhood Brain Cancer: In mouse models of DIPG, simultaneously attacking two metabolic pathways led to significant improvements in survival.
8. Study Suggests New Approach to Improve Radiation Therapy Resistance in Glioblastoma: Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against these aggressive brain tumors.
9. This MicroRNA Might Help Detect, Treat Ovarian Cancer: In cell and mouse models, miR181a showed promise as a biomarker for early stage ovarian cancer and may help make immunotherapy treatment more effective.
10. Clinical Trial Offers Clues About Why Some Metastatic Prostate Cancers Don’t Respond to Anti-Androgen Therapy: Transcriptional profiling identifies a gene program active in metastatic prostate cancers that failed to respond to enzalutamide treatment.
For more information and further details, Visit https://www.imedpub.com/cancer-epidemiology-and-prevention/.
Multidisciplinary journal representing the study of factors responsible for the initiation, metastasis and prognosis of various types of cancer.
Researchers may submit their novel writings in the field of oncology via our online portal or as an attachment to mail.
Email us at cancerepidemol@eclinicalsci.org or cancerepidemol@scholarlypub.com